Delcath Systems, Inc. (Nasdaq: DCTH), ("Delcath" or the "Company") an interventional oncology company focused on the ...

About 10% of adolescents and young adults treated for solid tumors have a metastatic recurrence, with 5-year rates surpassing ...

METAvivor focuses solely on supporting people with metastatic breast cancer. The organization offers information and support ...

In this study, researchers explored disparities in metastatic cutaneous melanoma survival following the introduction of immunotherapies.

In August, Plus Therapeutics announced the launch of the CNSide diagnostic platform, a proprietary, highly sensitive, cerebrospinal fluid (CSF) assay platform performed in a Clinical Laboratory ...

This satellite symposium at the European Society for Medical Oncology (ESMO) Congress 2025, chaired by Rana McKay, Professor ...

Lytgobi (futibatinib) marks the first medicine launched by Taiho Oncology Europe in the UK (2) For United Kingdom (UK) Trade and Medical Media Only ...

A new study of adolescents and young adults (AYAs) with seven common cancers reveals that nearly one in ten patients ...

I am now 36 years old and live in Georgia with my husband, Jesse, and our three dogs: Charlie, Lola, and Obi-Wan. Before I ...

A cancer diagnosis changes life in several ways, but when cancer becomes metastatic, meaning the disease spreads beyond the ...

CatalYm today announced that the first patient has been dosed in the randomized Phase 2b GDFATHER‑NSCLC‑02 (GDF‑15 ...

NeOnc Technologies Holdings, Inc. (Nasdaq: NTHI), a clinical-stage biopharmaceutical company developing brain-penetrant therapeutics for central nervous system (CNS) cancers, today announced newly ...